RESEARCH ARTICLE


Intra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer



Asha Paul, K.M .Fathima, Sreeja C. Nair*
Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Amrita University, AIMS Health Science Campus, Kochi, India


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 1773
Abstract HTML Views: 453
PDF Downloads: 472
ePub Downloads: 399
Total Views/Downloads: 3097
Unique Statistics:

Full-Text HTML Views: 907
Abstract HTML Views: 306
PDF Downloads: 204
ePub Downloads: 136
Total Views/Downloads: 1553



© 2017 Paul et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4. 0 International Public License (CC-BY 4. 0), a copy of which is available at: https://creativecommons. org/licenses/by/4. 0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Amrita University, AIMS Health Science Campus, Kochi, India, Tel: 09388600399; E-mail: sreejacnair@aims.amrita.edu


Abstract

Background:

A novel drug delivery system for treating acute epileptic condition.

Objective:

To develop an intranasal mucoadhesive formulation of Lamotrigine (LTG) loaded insitu gel, for the treatment of epilepsy to avoid possible side effects and first pass metabolism associated with conventional treatment.

Methods:

Lamotrigine was loaded into different polymeric solutions of gellan and xanthan gum.

Results:

All formulations subjected to various evaluation studies were within their acceptable limits. The pH of formulation ranges between 5.8 ±.001 to 6.8 ±.005 indicating that no mucosal irritation is expected as pH was in acceptable range. Invitro drug release from the mucoadhesive insitu gel formulations showed immediate drug release pattern with a maximum drug release of 97.02 ±0.54% for optimized G5 formulation within 20min. Exvivo permeation studies of optimized formulation G5 and control formulation was estimated. Exvivo permeation studies of G5 insitu formulation done for a period of 12 h resulted in slow, sustained release and greater permeability significance(P <0.05) through nasal mucosa when compared to control. Histopathological studies showed that G5 formulation was safer for nasal administration without any irritation. The stability studies indicated that gels were stable over 45 days in refrigerated condition (4±2ºC).

Conclusion:

The intranasal insitu gelling system is a promising novel drug delivery system for an antiepileptic drug lamotrigine which could enhance nasal residence time with increased viscosity and mucoadhesive character and provided better release profile of drug for treating acute epileptic conditions.

Keywords: Intranasal formulation, Mucoadhesion, Insitu gel, Immediate release, Acute epileptic condition, Ex vivo permeation.